Optimizing Treatment for Children in the Developing World
Herausgegeben:Macleod, Stuart; Hill, Suzanne; Koren, Gideon; Rane, Anders
Optimizing Treatment for Children in the Developing World
Herausgegeben:Macleod, Stuart; Hill, Suzanne; Koren, Gideon; Rane, Anders
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book is intended to communicate current best practice in pediatric clinical pharmacology and clinical pharmacy with special consideration of the prevailing circumstances and most pressing needs in developing countries. It also addresses measures that may be taken in countries with emerging economies through organizational and political adjustments to reduce unacceptable levels of morbidity and mortality among children and pregnant women with treatable diseases.
Andere Kunden interessierten sich auch für
- Optimizing Treatment for Children in the Developing World37,99 €
- Ricardo H AlvarezHandbook of HER2-targeted agents in breast cancer30,99 €
- Pharmacological Treatment of Acute Coronary Syndromes30,99 €
- Anna BurkePocket Reference to Alzheimer's Disease Management37,99 €
- Yee Guan YapEssentials of Atrial Fibrillation41,99 €
- Clinical Handbook of Bereavement and Grief Reactions88,99 €
- Nanoscale Materials in Targeted Drug Delivery, Theragnosis and Tissue Regeneration110,99 €
-
-
-
This book is intended to communicate current best practice in pediatric clinical pharmacology and clinical pharmacy with special consideration of the prevailing circumstances and most pressing needs in developing countries. It also addresses measures that may be taken in countries with emerging economies through organizational and political adjustments to reduce unacceptable levels of morbidity and mortality among children and pregnant women with treatable diseases.
Produktdetails
- Produktdetails
- Verlag: Adis / Springer International Publishing / Springer, Berlin
- Artikelnr. des Verlages: 978-3-319-38058-2
- Softcover reprint of the original 1st ed. 2015
- Seitenzahl: 352
- Erscheinungstermin: 17. Oktober 2016
- Englisch
- Abmessung: 235mm x 155mm x 20mm
- Gewicht: 534g
- ISBN-13: 9783319380582
- ISBN-10: 3319380583
- Artikelnr.: 46434014
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
- Verlag: Adis / Springer International Publishing / Springer, Berlin
- Artikelnr. des Verlages: 978-3-319-38058-2
- Softcover reprint of the original 1st ed. 2015
- Seitenzahl: 352
- Erscheinungstermin: 17. Oktober 2016
- Englisch
- Abmessung: 235mm x 155mm x 20mm
- Gewicht: 534g
- ISBN-13: 9783319380582
- ISBN-10: 3319380583
- Artikelnr.: 46434014
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
Since 2003, Dr Stuart MacLeod has been Professor of Pediatrics at the University of British Columbia in Vancouver, Canada. He was also Director of the Child & Family Research Institute at BC Children's Hospital until January 2010 and remains a senior clinician scientist at the Institute. Dr MacLeod received an MD from the University of Toronto in 1967 and completed postgraduate training in clinical pharmacology in 1973 at McGill University where he obtained a PhD in pharmacology in 1972. In the early stages of his career his research interests focused on biochemical pharmacology, drug hepatotoxicity and drug biotransformation. In 1979 Dr MacLeod became the founding leader of a Division of Pediatric Clinical Pharmacology at Toronto's Hospital for Sick Children. This University of Toronto unit has now thrived for 35 years and is the world's leading centre for training and research in pediatric pharmacology and toxicology. Dr MacLeod served as Dean of the Faculty of Health Sciences at McMaster University (1987-1992) and following the deanship founded the Centre for Evaluation of Medicines with a focus on therapeutics teaching, clinical pharmacology, population health sciences and pharmacoepidemiology. Since 1986, Dr MacLeod has held a major interest in international health with a focus on African maternal-child health. His current scientific interests embrace the multitude of factors that influence safe and effective drug treatments for children and the use of research findings to inform clinical and public policy.
Foreword.- Shifting demographics and regional disparities.- Access issues.- Ending stockouts.- Improved formulations and optimal dosing.- Deficient and counterfeit products.- Knowledge gaps in pregnancy and lactation.- Factors enabling improved therapy.- Regulatory science.- Human resource planning.- Information and communications technology.- Pharmaceutical care.- Networks (GRIP, INRUD, MSH, PTN,MYCRN, IABMC).- Research challenges.- Research standards for clinical trials in low and middle income countries.- Innovative appropriate trial methods.- Nutrition/micronutrients.- Impact on therapeutic outcomes.- Drug safety and pharmaco-epidemiology.- Personalized treatment and Pharmacogenomics.- Neglected diseases.- Health outcomes and economics.- Enhanced industry engagement.- Incorporating social science perspectives.- Clinical settings.- Treatment in the community.- Treatment at the district hospital level.- Care of the critically ill child.- Palliative care and pain management. - Conclusion.- The light at the end of the tunnel: future directions.
Foreword.- Shifting demographics and regional disparities.- Access issues.- Ending stockouts.- Improved formulations and optimal dosing.- Deficient and counterfeit products.- Knowledge gaps in pregnancy and lactation.- Factors enabling improved therapy.- Regulatory science.- Human resource planning.- Information and communications technology.- Pharmaceutical care.- Networks (GRIP, INRUD, MSH, PTN,MYCRN, IABMC).- Research challenges.- Research standards for clinical trials in low and middle income countries.- Innovative appropriate trial methods.- Nutrition/micronutrients.- Impact on therapeutic outcomes.- Drug safety and pharmaco-epidemiology.- Personalized treatment and Pharmacogenomics.- Neglected diseases.- Health outcomes and economics.- Enhanced industry engagement.- Incorporating social science perspectives.- Clinical settings.- Treatment in the community.- Treatment at the district hospital level.- Care of the critically ill child.- Palliative care and pain management. - Conclusion.- The light at the end of the tunnel: future directions.